Nyxoah Reports First Quarter 2024 Financial and Operating Results Read more about Nyxoah Reports First Quarter 2024 Financial and Operating Results
Nyxoah to Release First Quarter 2024 Financial Results on May 14, 2024 Read more about Nyxoah to Release First Quarter 2024 Financial Results on May 14, 2024
Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 12, 2024 Read more about Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 12, 2024
Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer Read more about Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer
Information on the total number of voting rights and shares Read more about Information on the total number of voting rights and shares
Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology – Head & Neck Surgery Foundation Read more about Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology – Head & Neck Surgery Foundation
Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary Endpoints Read more about Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary Endpoints
Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating Results Read more about Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating Results
Nyxoah to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference Read more about Nyxoah to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
Nyxoah to Release Fourth Quarter and Financial Year 2023 Financial Results on March 5, 2024 Read more about Nyxoah to Release Fourth Quarter and Financial Year 2023 Financial Results on March 5, 2024